Community Health Sys (NYSE:CYH) Bolsa

Community Health Sys

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Community Health Systems

Community Health Systems, Inc. Common Stock

Community Health Systems Inc

Truist Securities analyst David Macdonald maintains Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Hold and raises the price target from $3.5 to $4.25.

News

Price Target

Analyst Ratings

Truist Securities Maintains Hold on Community Health Sys, Raises Price Target to $4.25

Wells Fargo analyst Stephen Baxter maintains Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Underweight and raises the price target from $2 to $3.5.

Wells Fargo Maintains Underweight on Community Health Sys, Raises Price Target to $3.5

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Thursday.
The Dow traded up 0.97% to 39,989.57 while the NASDAQ gained 2.24% to 17,082.79. The S&amp;P 500 also rose, gaining, 1.69% to 5,466.54.
Check This Out: <a href="https://www.benzinga.com/25/04/44947241/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-stocks-with-over-4-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Tech Stocks With Over 4% Dividend Yields</a>
Leading and Lagging Sectors Information technology shares jumped by 2.5% on Thursday.
In trading on Thursday, consumer staples fell by 1.2%.
Top Headline
Bristol Myers Squibb &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) reported better-than-expected first-quarter results.
The company posted quarterly revenues of $11.20 billion, beating the consensus of $10.70 billion. The company reported an adjusted EPS of $1.80, a turnaround from a loss of $4.40 a year ago, beating the consensus of $1.49.
Bristol Myers Squibb raised its fiscal year 2025 adjusted EPS from $6.55-$6.85 to $6.70-$7.00 compared to consensus of $6.74.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares shot up 24% to $3.0250 after the company reported better-than-expected first-quarter financial results.</li>
<li>Shares of TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>)got a boost, surging 34% to $3.4255 following a Reuters report indicating President Trump is expected to sign an executive order to advance the deep sea mining industry.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) shares were also up, gaining 32% to $1.05 after the company announced the key clinical trial site location for its Phase 1 CER-1236 trial.</li>
</ul>
Equities Trading DOWN
<ul>
<li>TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) shares dropped 16% to $9.18 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Shares of Fiserv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) were down 16% to $181.90 after the company issued FY25 adjusted EPS guidance with its midpoint below estimates.</li>
<li>ASGN Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) was down, falling 15% to $49.78 following weaker-than-expected quarterly earnings.</li>
</ul>
Commodities In commodity news, oil traded up 0.3% to $62.48 while gold traded up 1.1% at $3,330.70.
Silver traded down 0.6% to $33.355 on Thursday, while copper fell 0.1% to $4.8395.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.36%, Germany's DAX 40 gained 0.49% and France's CAC 40 gained 0.26%. Spain's IBEX 35 Index fell 0.40%, while London's FTSE 100 rose 0.05%.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 surging 0.49%, China's Shanghai Composite gaining 0.03%, Hong Kong's Hang Seng Index falling 0.74% and India's BSE Sensex falling 0.39%.
Economics
<ul>
<li>U.S. natural-gas stocks increased 88 billion cubic feet during the week ending April 18, compared to market estimates of 65 bcf gain.</li>
<li>U.S. existing home sales fell by 5.6% from the previous month to an annualized rate of 4.02 million units in March.</li>
<li>The Chicago Fed National Activity Index declined to -0.03 in March compared to a reading of +0.24 in February.</li>
<li>U.S. initial jobless claims climbed by 6,000 from the previous week to 222,000 during the third week of April.</li>
<li>U.S. durable goods orders gained by 9.2% month-over-month to $315.7 billion in March.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44976958/jim-cramer-arista-networks-is-down-way-too-much-likes-uber-very-much">Jim Cramer: Arista Networks Is &#8216;Down Way Too Much,&#8217; Uber &#8216;Goes Higher&#8217;</a> </li>
</ul>
Photo via Shutterstock

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ASGN

CERO

Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results

<h3>Gainers</h3>
<ul>
<li>CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) stock moved upwards by 37.6% to $1.1 during Thursday's regular session. The company's market cap stands at $5.9 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares increased by 26.43% to $0.4. The market value of their outstanding shares is at $9.2 million. </li>
<li>Zhengye Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) shares increased by 24.8% to $9.76. The market value of their outstanding shares is at $462.5 million. </li>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares increased by 24.69% to $3.03. The market value of their outstanding shares is at $420.9 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) shares increased by 23.43% to $0.79. The market value of their outstanding shares is at $19.1 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares moved upwards by 19.94% to $8.0. The market value of their outstanding shares is at $5.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>NuCana (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNA#NASDAQ">NCNA</a>) shares decreased by 26.3% to $0.66 during Thursday's regular session. The company's market cap stands at $3.9 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares decreased by 23.85% to $0.99. The company's market cap stands at $15.0 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares declined by 16.08% to $3.08. The company's market cap stands at $5.0 million. </li>
<li>Metsera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) stock fell 15.17% to $20.0. The company's market cap stands at $2.1 billion. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock declined by 12.5% to $0.28. The market value of their outstanding shares is at $2.2 million. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares decreased by 11.41% to $0.87. The market value of their outstanding shares is at $5.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BSGM

ENSC

INTS

JAGX

MTSR

NCNA

PSTV

RNAZ

VTAK

ZYBT

12 Health Care Stocks Moving In Thursday's Intraday Session

U.S. stocks were higher, with the Nasdaq Composite gaining around 300 points on Thursday.
Shares of Texas Instruments Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) rose sharply during Thursday's session after the company reported first-quarter financial results and beat its <a href="https://in.benzinga.com/trading-ideas/movers/25/04/44984438/whats-going-on-with-texas-instruments-stock-thursday">EPS and sales estimates</a>.
Texas Instruments reported earnings per share of $1.28, beating analysts' estimate of $1.07. In addition, the company reported sales of $4.07 billion, beating analysts' estimate of $3.91 billion and representing an 11% year-over-year growth.
The company also issued guidance for the second-quarter. It sees earnings per share from $1.21 to $1.47, versus analysts' estimate of $1.23. Furthermore, it sees sales from $4.17 billion to $4.53 billion, versus analysts' estimate of $4.13 billion.
Texas Instruments shares gained 6.3% to $161.75 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) shares jumped 31.8% to $3.36 following a Reuters report indicating President Trump is expected to sign an executive order to advance the deep sea mining industry.</li>
<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) surged 27% to $3.0850 after the company reported better-than-expected first-quarter financial results.</li>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) gained 27% to $6.91 after the announcement that Hesai&#8217;s lidar sensor technology was selected for Pony&#8217;s AI robotaxis.</li>
<li>Ardagh Metal Packaging S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBP#NYSE">AMBP</a>) rose 25.7% to $3.47 after the company reported a year-over-year increase in first-quarter adjusted EPS results and better-than-expected revenue results. Additionally, the company raised its FY25 adjusted EBITDA guidance.</li>
<li>Lufax Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>) gained 18.8% to $3.1150.</li>
<li>Impinj, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) jumped 18% to $90.98 after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates.</li>
<li>Hasbro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAS#NASDAQ">HAS</a>) gained 15% to $60.60 after the company reported better-than-expected quarterly financial results.</li>
<li>ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) jumped 14.7% to $932.10 after the company reported better-than-expected quarterly financial results.</li>
<li>Allegion plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLE#NYSE">ALLE</a>) gained 10.7% to $139.94 following a first-quarter adjusted EPS and revenue beat.</li>
<li>ResMed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) gained 10.2% to $236.36 after the company reported better-than-expected quarterly adjusted EPS results. Also, Keybanc maintained an Overweight rating on the stock and raised its price target from $269 to $274.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) gained 10% to $48.27.</li>
<li>Microchip Technology Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>) jumped 9.6% to $45.96.</li>
<li>CACI International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) gained 9.5% to $463.80 after the company reported better-than-expected third-quarter financial results and raised its FY25 guidance.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) rose 8.7% to $24.39.</li>
<li>United Rentals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) gained 8.5% to $639.25 after the company reported better-than-expected quarterly sales results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44948767/top-2-consumer-stocks-that-may-implode-this-month">Top 2 Consumer Stocks That May Implode This Month</a></li>
</ul>

ALLE

AMBP

ASTS

CACI

LSCC

MCHP

PONY

Texas Instruments Posts Better-Than-Expected Results, Joins Community Health Systems, Hasbro, ServiceNow, ResMed And Other Big Stocks Moving Higher On Thursday

<h3>Gainers</h3>
<ul>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) shares increased by 13.7% to $0.99 during Thursday's pre-market session. The market value of their outstanding shares is at $4.3 million. </li>
<li>GlycoMimetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLYC#NASDAQ">GLYC</a>) shares increased by 13.32% to $0.27. The company's market cap stands at $17.4 million. </li>
<li>Avanos Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVNS#NYSE">AVNS</a>) stock rose 12.55% to $13.99. The market value of their outstanding shares is at $643.5 million. </li>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares moved upwards by 11.11% to $2.7. The market value of their outstanding shares is at $375.0 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>NovoCure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) shares rose 8.49% to $19.28. The market value of their outstanding shares is at $2.1 billion. As per the press release, Q1 earnings came out today. </li>
<li>CERo Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) shares rose 8.2% to $0.86. The company's market cap stands at $4.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Forian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORA#NASDAQ">FORA</a>) shares decreased by 32.6% to $1.26 during Thursday's pre-market session. The company's market cap stands at $39.3 million. </li>
<li>X4 Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XFOR#NASDAQ">XFOR</a>) stock decreased by 23.45% to $0.15. The company's market cap stands at $26.7 million. </li>
<li>Relmada Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLMD#NASDAQ">RLMD</a>) stock fell 22.44% to $0.54. The company's market cap stands at $17.7 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares declined by 15.26% to $3.11. The market value of their outstanding shares is at $5.1 million. </li>
<li>Atara Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATRA#NASDAQ">ATRA</a>) shares decreased by 13.05% to $6.0. The market value of their outstanding shares is at $35.1 million. </li>
<li>Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) stock decreased by 12.68% to $1.24. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATRA

AVNS

FORA

GLYC

NUWE

NVCR

RLMD

SONN

XFOR

12 Health Care Stocks Moving In Thursday's Pre-Market Session

WIIM

Community Health Systems shares are trading higher after the company reported better-than-expected Q1 financial results.

Shares of ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) rose sharply in today's pre-market trading after the company reported <a href="https://in.benzinga.com/news/earnings/25/04/44966273/servicenow-stock-surges-on-q1-earnings-beat-company-says-its-positioned-as-the-platinum-standard-for-enterprise-grade-ai">better-than-expected first-quarter financial results.</a>
ServiceNow reported first-quarter revenue of $3.09 billion, beating the consensus estimate of $3.08 billion, according to Benzinga Pro. The company reported first-quarter adjusted earnings of $4.04 per share, beating analyst estimates of $3.84 per share.
ServiceNow shares jumped 9% to $886.00 in pre-market trading
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>CN Energy Group. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>) rose 95.9% to $0.2490 in pre-market trading.</li>
<li>Wag! Group Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) surged 55.6% to $0.1719 in pre-market trading after gaining 17% on Wednesday. Wag! Group recently reported fourth-quarter financial results and missed its EPS and sales estimates.</li>
<li>Linkage Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCB#NASDAQ">LGCB</a>) gained 37.2% to $2.62 in pre-market. Linkage Global regained compliance with Nasdaq Bid Price Requirement.</li>
<li>Mustang Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIO#NASDAQ">MBIO</a>) surged 35.3% to $1.80 in pre-market trading after gaining around 4% on Wednesday.</li>
<li>Solidion Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) rose 35.1% to $0.1385 in pre-market trading after gaining over 5% on Wednesday.</li>
<li>Cantor Equity Partners, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEP#NASDAQ">CEP</a>) gained 20.9% to $19.94 in pre-market trading after gaining around 54% on Wednesday.</li>
<li>Impinj, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) jumped 15.8% to $89.26 in pre-market trading after the company reported better-than-expected first-quarter financial results and issued second-quarter guidance above estimates.</li>
<li>Kearny Financial Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNY#NASDAQ">KRNY</a>) gained 11.2% to $6.85 in pre-market trading ahead of quarterly earnings.</li>
<li>Community Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) gained 11.1% to $2.70 in pre-market trading after the company reported better-than-expected first-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Greenlane Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) fell 92% to $0.0196 in pre-market trading after dipping 8% on Wednesday.</li>
<li>Relmada Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLMD#NASDAQ">RLMD</a>) shares fell 26.2% to $0.5079 in pre-market trading after jumping around 82% on Wednesday.</li>
<li>AGM Group Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>) shares fell 22.1% to $0.0452 in pre-market trading after jumping 93% on Wednesday. AGM Group Holdings recently received a Nasdaq Determination Notice.</li>
<li>Alpha Cognition Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACOG#NASDAQ">ACOG</a>) shares dipped 18.5% to $4.01 in pre-market trading after gaining 8% on Wednesday.</li>
<li>Ensysce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares tumbled 18.3% to $3.00 in pre-market trading after the company announced exercise of warrants for $2.2 million gross proceeds.</li>
<li>TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) fell 17.8% to $9.02 in pre-market trading after the company announced weaker-than-expected quarterly results.</li>
<li>Robert Half Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHI#NYSE">RHI</a>) declined 16.6% to $38.70 in pre-market trading after the company reported worse-than-expected quarterly financial results.</li>
<li>Acacia Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) fell 11.1% to $2.65 in pre-market trading.</li>
<li>Latham Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) fell 10.3% to $4.98 in today's pre-market trading. Latham Group will release financial results for the first quarter on Tuesday, May 6, after the closing bell.</li>
<li>Kaiser Aluminum Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALU#NASDAQ">KALU</a>) dipped 8.2% to $54.10 in pre-market trading following weak quarterly sales.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44948767/top-2-consumer-stocks-that-may-implode-this-month">Top 2 Consumer Stocks That May Implode This Month</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

ACOG

ACTG

AGMH

CNEY

GNLN

KALU

KRNY

LGCB

MBIO

SWIM

Why ServiceNow Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

<h3>Gainers</h3>
<ul>
<li>Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) shares rose 13.2% to $2.75 during Wednesday's after-market session. The company's market cap stands at $382.0 million. As per the press release, Q1 earnings came out today. </li>
<li>Candel Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CADL#NASDAQ">CADL</a>) stock increased by 11.55% to $5.31. The company's market cap stands at $250.8 million. </li>
<li>Ovid Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) stock increased by 8.61% to $0.35. The company's market cap stands at $25.0 million. </li>
<li>Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) stock moved upwards by 7.6% to $0.28. The company's market cap stands at $73.8 million. </li>
<li>Vanda Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNDA#NASDAQ">VNDA</a>) stock increased by 7.18% to $4.64. The market value of their outstanding shares is at $270.6 million. </li>
<li>Clearside Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSD#NASDAQ">CLSD</a>) shares rose 6.83% to $0.85. The company's market cap stands at $65.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Relmada Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLMD#NASDAQ">RLMD</a>) shares declined by 20.4% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $17.8 million. </li>
<li>Ensysce Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) shares decreased by 19.62% to $2.95. The company's market cap stands at $4.1 million. </li>
<li>Citius Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) stock fell 9.33% to $0.61. The market value of their outstanding shares is at $43.4 million. </li>
<li>Zhengye Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) shares fell 8.03% to $7.34. The company's market cap stands at $347.8 million. </li>
<li>60 Degrees (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SXTP#NASDAQ">SXTP</a>) shares fell 6.98% to $2.8. The market value of their outstanding shares is at $4.1 million. </li>
<li>INVO Fertility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAYA#NASDAQ">NAYA</a>) stock decreased by 6.12% to $1.8. The company's market cap stands at $8.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADAP

CADL

CLSD

CTOR

NAYA

OVID

SXTP

VNDA

12 Health Care Stocks Moving In Wednesday's After-Market Session

Guidance

Community Health Systems Reaffirms FY2025 EPS Guidance $(0.55)-$0 vs $(0.32) Est

Community Health Systems Reaffirms Annual Earnings Guidance For 2025, Issued On Feb. 15

Earnings Beats

Community Health Sys Q1 Adj. EPS $(0.03) Beats $(0.08) Estimate, Sales $3.16B Beat $3.10B Estimate

AMTB

BANC

BPOP

BRKL

BWFG

CBAN

CHDN

CHKP

COOP

CSLR

CVLG

New Oriental Education & Technology Group

EGBN

EPRT

GATX

GLPG

GSHD

HBNC

HCSG

IMAX

INBK

KREF

LRCX

MTDR

ODFL

ORLY

OSBC

OTIS

PLXS

PTEN

SEIC

Earnings Scheduled For April 23, 2025

Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-04-23. Here's what investors need to know before the announcement.
Analysts estimate that Community Health Sys will report an earnings per share (EPS) of $-0.08. 
Investors in Community Health Sys are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Earnings History Snapshot</h3>
During the last quarter, the company reported an EPS missed by $0.37, leading to a 7.76% increase in the share price on the subsequent day.
Here's a look at Community Health Sys's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.05</td>
<td>-0.18</td>
<td>-0.12</td>
<td>-0.16</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.42</td>
<td>-0.30</td>
<td>-0.17</td>
<td>-0.14</td>
</tr>
<tr>
<td>Price Change %</td>
<td>8.0%</td>
<td>-23.0%</td>
<td>10.0%</td>
<td>7.000000000000001%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745355742_0.png" alt="eps graph" />
<h3>Performance of Community Health Sys Shares</h3>
Shares of Community Health Sys were trading at $2.39 as of April 21. Over the last 52-week period, shares are down 20.46%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CYH/earnings">To track all earnings releases for Community Health Sys visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Community Health Sys's Upcoming Earnings

Community Health Systems shares are trading higher after the company announced that it entered into a definitive agreement to sell their collective 80% ownership interest in Cedar Park Regional Medical Center and certain ancillary businesses.

Asset Sales

Community Health Systems Announces Definitive Agreement to Sell 80% Interest In Cedar Park Regional Medical Center For $460M

Truist Securities analyst David Macdonald maintains Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Hold and lowers the price target from $4 to $3.

Truist Securities Maintains Hold on Community Health Sys, Lowers Price Target to $3

Guggenheim analyst Jason Cassorla initiates coverage on Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Neutral rating.

Initiation

Guggenheim Initiates Coverage On Community Health Sys with Neutral Rating

Wells Fargo analyst Stephen Baxter maintains Community Health Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYH#NYSE">CYH</a>) with a Underweight and lowers the price target from $2.5 to $2.

Wells Fargo Maintains Underweight on Community Health Sys, Lowers Price Target to $2

Press Releases

Community Health Systems Completes Divestiture of Mooresville, North Carolina Hospital to Duke Health

Community Health Systems to Webcast First Quarter 2025 Conference Call

Community Health Systems Announces Definitive Agreement to Sell Ownership Interest in Cedar Park Regional Medical Center in Texas

Community Health Systems, Inc. Announces First Quarter Ended March 31, 2025 Results

Community Health Systems, Inc. Announces Sale of $700 Million Aggregate Principal Amount of 10.750% Senior Secured Notes Due 2033

Community Health Systems, Inc. Announces Commencement of Cash Tender Offer for 6.875% Senior Unsecured Notes Due 2028

Community Health Systems, Inc. Announces Early Tender Results of Previously Announced Tender Offer for 6.875% Senior Unsecured Notes Due 2028

Community Health Systems to Participate in 2025 RBC Capital Markets Global Healthcare Conference

Community Health Systems Completes Divestiture of Cedar Park Regional Medical Center in Texas

Comments

Community Health Sys

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL